These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17523588)

  • 1. Effectiveness of different models of case management for substance-abusing populations.
    Vanderplasschen W; Wolf J; Rapp RC; Broekaert E
    J Psychoactive Drugs; 2007 Mar; 39(1):81-95. PubMed ID: 17523588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based case management effectiveness in populations that abuse substances.
    Joo JY; Huber DL
    Int Nurs Rev; 2015 Dec; 62(4):536-46. PubMed ID: 26058816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the impact of case management dosage.
    Huber DL; Sarrazin MV; Vaughn T; Hall JA
    Nurs Res; 2003; 52(5):276-88. PubMed ID: 14501542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-ordination and continuity of care in substance abuse treatment. An evaluation study in Belgium.
    Vanderplasschen W; De Bourdeaudhuij I; Van Oost P
    Eur Addict Res; 2002 Jan; 8(1):10-21. PubMed ID: 11818689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of centralized intake on case management services.
    Scott CK; Sherman RE; Foss MA; Godley M; Hristova L
    J Psychoactive Drugs; 2002; 34(1):51-7. PubMed ID: 12003113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to promote successful re-entry among drug-abusing parolees.
    Prendergast ML
    Addict Sci Clin Pract; 2009 Apr; 5(1):4-13. PubMed ID: 19369913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of case management on rural women's quality of life and substance use.
    Passey M; Sheldrake M; Leitch K; Gilmore V
    Rural Remote Health; 2007; 7(3):710. PubMed ID: 17683243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Iowa case management on provisions of social support for substance abuse clients.
    Sarrazin MV; Hall JA
    Care Manag J; 2004; 5(1):3-11. PubMed ID: 15792325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage to medical services in the Drug Abuse Treatment Outcome Study.
    Friedmann PD; Lemon SC; Stein MD; Etheridge RM; D'Aunno TA
    Med Care; 2001 Mar; 39(3):284-95. PubMed ID: 11242322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Client satisfaction with rural substance abuse case management services.
    Kopelman T; Huber DL; Kopelman BC; Sarrazin MV; Hall JA
    Care Manag J; 2006; 7(4):179-90. PubMed ID: 17194054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fidelity of an outreach treatment program for chronic crack abusers in the Netherlands to the ACT model.
    Henskens R; Garretsen H; Mulder CL; Bongers I; Kroon H
    Psychiatr Serv; 2005 Nov; 56(11):1451-4. PubMed ID: 16282268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an outreach treatment program for inner city crack abusers: compliance, outcome, and client satisfaction.
    Henskens R; Garretsen H; Bongers I; Van Dijk A; Sturmans F
    Subst Use Misuse; 2008; 43(10):1464-75. PubMed ID: 18615321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse interventions for parents involved in the child welfare system: evidence and implications.
    Osterling KL; Austin MJ
    J Evid Based Soc Work; 2008; 5(1-2):157-89. PubMed ID: 19064448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the organization, management, and outcomes of substance abuse treatment programs.
    Heinrich CJ; Lynn LE
    Am J Drug Alcohol Abuse; 2002 Nov; 28(4):601-22. PubMed ID: 12492259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.